Cointime

Cellective Therapeutics

company

About

Cellective Therapeutics is a biopharmaceutical company that engages in B Cell research for cancer and autoimmune diseases.

Highlights

Total Funding Amount
$27.50M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series A
Last Funding Money Raised
$27.50M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2003
Operating Status
Active

Cellective Therapeutics is a biopharmaceutical company that engages in B Cell research for cancer and autoimmune diseases. Cellective focuses on monoclonal antibodies, which, with the company's technology, can be developed so specifically that they block the root causes of autoimmunity without interfering with the body's normal response to infections.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$27.50M
Cellective Therapeutics has raised a total of $27.50M in funding over 2 rounds. Their latest funding was raised on Sep 29, 2004 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 29, 2004 Series A $27.50M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Cellective Therapeutics is funded by 1 investors. BA Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
BA Venture Partners — Series A
Cointime
เนื้อหา
บริษัท